Caveolin-1, CAV-1
Caveolin-1 is a 22 kDa membrane protein
which is expressed by mesenchymal cells. It is a structural component
of caveolae, 80 to 100 nm omega-shaped vesicular invaginations of the
plasma membrane2,3.
It has putative functions in vesicular transport, cholesterol homeostasis,
cell migration, cell cycle and cell polarity regulation. It is commonly
up-regulated in malignant neoplasms. Cav1 has been variously reported
to impact both positively and negatively on various aspects of tumour
progression, being both reported to function as a tumour suppressor and
identified as a poor prognostic factor in various human cancers4,5. It reportedly expression correlates
with drug resistance and a poor prognosis in advanced non-small cell lung
cancer patients treated with gemcitabine-based chemotherapy10. However, it is also said to
be down-regulated in human lung carcinoma, acting as a candidate tumour
suppressor gene11.
Caveolin-1 is also thought to play an important roles in organogenesis6 and atherosclerosis7.
Immunohistochemical expression
- Endothelial cells
- Smooth muscle cells
- Type I and II pneumocytes: type I pneumocytes have caveolae,
some of which show immunogold localisation of caveolin. Type
II pneumocytes label for caveolin but lack caveolae8.
- Mesothelial cells9
In lung carcinomas, staining is predominantly
membrane with cytoplasmic staining in a minority of cases12. There is variation in the rate
of expression with subtype. Primary tumours showing metastatic spread
are more often positive for caveolin-1. Brain but not adrenal metastases
may acquire positivity where the primary lung tumour was negative12.
|
Status of primary lung tumour |
Brain metastasis |
Adrenal metastasis |
|
|
Caveolin negative |
Caveolin positive |
Caveolin negative |
Caveolin positive |
Caveolin negative |
1612
|
1112
|
912 |
012 |
Caveolin positive |
012 |
712 |
012 |
112 |
|
|
|
|
|
Diagnostic utility
Differentiation of epithelioid mesothelioma
from pulmonary adenocarcinoma:
References
1 Amatya, V. J., Y. Takeshima, et al. (2009). "Caveolin-1
is a novel immunohistochemical marker to differentiate epithelioid mesothelioma
from lung adenocarcinoma." Histopathology 55(1): 10-19.
2 Glenney,
J. R., Jr. and D. Soppet (1992). "Sequence and expression of caveolin,
a protein component of caveolae plasma membrane domains phosphorylated
on tyrosine in Rous sarcoma virus-transformed fibroblasts." Proc
Natl Acad Sci U S A 89(21): 10517-10521.
3 Rothberg,
K. G., J. E. Heuser, et al. (1992). "Caveolin, a protein component
of caveolae membrane coats." Cell 68(4): 673-682.
4 Goetz,
J. G., P. Lajoie, et al. (2008). Caveolin-1 in tumor progression: the
good, the bad and the ugly. Cancer Metastasis Rev 27(4): 715-735.
5 Quest, A. F., J. L. Gutierrez-Pajares, et
al. (2008). "Caveolin-1: an ambiguous partner in cell signalling
and cancer." J Cell Mol Med 12(4): 1130-1150.
6 Fang,
P. K., K. R. Solomon, et al. (2006). Caveolin-1alpha and -1beta perform
nonredundant roles in early vertebrate development. Am J Pathol 169(6):
2209-2222.
7 Frank,
P. G., S. E. Woodman, et al. (2003). Caveolin, caveolae, and endothelial
cell function. Arterioscler Thromb Vasc Biol 23(7): 1161-1168.
8 Newman,
G. R., L. Campbell, et al. (1999). "Caveolin and its cellular and
subcellular immunolocalisation in lung alveolar epithelium: implications
for alveolar epithelial type I cell function." Cell Tissue Res 295(1):
111-120.
9
von
Ruhland CJ, Campbell L, Gumbleton M, Jasani B, Newman GR. Immunolocalization
of caveolin-1 in rat and human mesothelium. J Histochem Cytochem. 2004
Nov;52(11):1415-25.
10
Ho
CC, Kuo SH, Huang PH, Huang HY, Yang CH, Yang PC. Caveolin-1 expression
is significantly associated with drug resistance and poor prognosis in
advanced non-small cell lung cancer patients treated with gemcitabine-based
chemotherapy. Lung Cancer. 2008 Jan;59(1):105-10.
11
Belanger
MM, Roussel E, Couet J. Caveolin-1 is down-regulated in human lung carcinoma
and acts as a candidate tumor suppressor gene. Chest. 2004 May;125(5 Suppl):106S.
12 Cassoni
P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, et al. Caveolin-1
expression in lung carcinoma varies according to tumour histotype and
is acquired de novo in brain metastases. Histopathology. 2009 Jul;55(1):20-7.
This page last revised 15.8.2009.
©SMUHT/PW
Bishop